[go: up one dir, main page]

RU2104023C1 - Лекарственное средство для лечения ретровирусных инфекций - Google Patents

Лекарственное средство для лечения ретровирусных инфекций Download PDF

Info

Publication number
RU2104023C1
RU2104023C1 RU95121821A RU95121821A RU2104023C1 RU 2104023 C1 RU2104023 C1 RU 2104023C1 RU 95121821 A RU95121821 A RU 95121821A RU 95121821 A RU95121821 A RU 95121821A RU 2104023 C1 RU2104023 C1 RU 2104023C1
Authority
RU
Russia
Prior art keywords
extracts
use according
coli
extract
ginkgo biloba
Prior art date
Application number
RU95121821A
Other languages
English (en)
Russian (ru)
Other versions
RU95121821A (ru
Inventor
Лафес Ханс-Георг
Original Assignee
Лафес Ханс-Георг
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Лафес Ханс-Георг filed Critical Лафес Ханс-Георг
Publication of RU95121821A publication Critical patent/RU95121821A/ru
Application granted granted Critical
Publication of RU2104023C1 publication Critical patent/RU2104023C1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/16—Ginkgophyta, e.g. Ginkgoaceae (Ginkgo family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Virology (AREA)
  • Medical Informatics (AREA)
  • Oncology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Communicable Diseases (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
RU95121821A 1993-03-17 1994-03-08 Лекарственное средство для лечения ретровирусных инфекций RU2104023C1 (ru)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DEP4308443.5 1993-03-17
DE4308443A DE4308443C2 (de) 1993-03-17 1993-03-17 Arzneimittel zur Behandlung von Retrovirusinfektionen
PCT/EP1994/000687 WO1994021269A1 (de) 1993-03-17 1994-03-08 Arzneimittel zur behandlung von retrovirusinfektionen

Publications (2)

Publication Number Publication Date
RU95121821A RU95121821A (ru) 1998-01-27
RU2104023C1 true RU2104023C1 (ru) 1998-02-10

Family

ID=6483010

Family Applications (1)

Application Number Title Priority Date Filing Date
RU95121821A RU2104023C1 (ru) 1993-03-17 1994-03-08 Лекарственное средство для лечения ретровирусных инфекций

Country Status (12)

Country Link
EP (1) EP0689446A1 (de)
JP (1) JP2735386B2 (de)
AU (1) AU684755B2 (de)
BR (1) BR9405887A (de)
CA (1) CA2158551A1 (de)
CZ (1) CZ238795A3 (de)
DE (1) DE4308443C2 (de)
HU (1) HUT73382A (de)
PL (1) PL310659A1 (de)
RU (1) RU2104023C1 (de)
SK (1) SK115495A3 (de)
WO (1) WO1994021269A1 (de)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2523154A1 (fr) * 1982-03-09 1983-09-16 Fabre Sa Pierre Procede de preparation de proteoglycanes immunostimulants inducteurs d'interferon, proteoglycanes obtenus et medicaments les contenant
FR2634380B1 (fr) * 1988-07-19 1990-10-12 Beljanski Mirko Regulateur biologique, actif dans diverses pathologies
DE3832056A1 (de) * 1988-09-21 1990-03-22 Scholle Helmut Dr Med Verwendung eines ginkgo-extraktes
FR2639830B1 (fr) * 1988-12-02 1991-03-22 Beljanski Mirko Composition antivirale et ses applications
DE4105570A1 (de) * 1991-02-22 1992-08-27 Helmut Dr Med Scholle Verwendung eines bakterien- und eiweissfreien filtrats

Also Published As

Publication number Publication date
PL310659A1 (en) 1995-12-27
WO1994021269A1 (de) 1994-09-29
BR9405887A (pt) 1995-12-12
HUT73382A (en) 1996-07-29
JP2735386B2 (ja) 1998-04-02
AU684755B2 (en) 1998-01-08
CZ238795A3 (en) 1996-02-14
CA2158551A1 (en) 1994-09-29
JPH08506595A (ja) 1996-07-16
AU6283494A (en) 1994-10-11
SK115495A3 (en) 1996-11-06
DE4308443C2 (de) 1996-09-19
HU9502697D0 (en) 1995-11-28
DE4308443A1 (de) 1994-09-22
EP0689446A1 (de) 1996-01-03

Similar Documents

Publication Publication Date Title
EP0559425B1 (de) Verwendung von Proteinen der Transferrin/Lactoferrin-Familie zur Stimulation des Immunsystems
Bodensteiner et al. Chronic ECHO type 5 virus meningoencephalitis in X‐linked hypogammaglobulinemia: Treatment with immune plasma
CN1191061C (zh) 药用组合物
HU204999B (en) Process for producing pharmaceutical compositions having antiviral activity and comprising synergetic active ingredient combination
RU2104023C1 (ru) Лекарственное средство для лечения ретровирусных инфекций
JPH0737393B2 (ja) 医薬組成物
CN1833644B (zh) 青蒿素及其衍生物二氢青蒿素、蒿甲醚、蒿乙醚、青蒿琥酯在制药中的应用
JP3217278B2 (ja) 落花生種皮処理物を用いた造血機能回復剤及び加工食品
JPH05331061A (ja) アポトーシス誘起剤
JP4580479B2 (ja) 抗ｈｉｖ感染症剤
JP3247381B2 (ja) 抗コレラトキシン剤
JP2001122795A (ja) 感染性疾患予防・治療剤
JP2005500995A (ja) Ｂ型肝炎ウイルスにより起きる感染症の治療または予防のためのフィランタス属構成部分の使用
CN106822152B (zh) 一种药物组合物及其应用
DE3780157T2 (de) Verwendung von 4-butyl-1,2-diphenyl-pyrazolidin-3,5-dion als antivirales arzneimittel gegen aids.
CN102727523A (zh) 一种具有抗hiv潜伏作用的药物及其用途
CN1327386A (zh) 抗hiv感染症剂及hiv感染症的治疗方法
KR100285586B1 (ko) 5-하드록시메틸-2-푸르푸랄을 함유하는 비형 간염 치료제
WO2002066022A1 (en) Retinoid hepatitis therapy
Kocięcka et al. The effect of Thymus Factor X (TFX Polfa) on the clinical course of human trichinellosis
US3856966A (en) Treatment of viral influenza infections
CN1857364A (zh) 一种含忍冬藤提取物的药物及制备方法
WO2021261599A1 (ja) 新型コロナウイルス感染症予防・治療剤
JP2889481B2 (ja) 血圧降下剤
CN111067898A (zh) 盐酸小檗碱在水产养殖中抗鲤疱疹病毒ⅱ型的用途